Allison Empey, M.D., will participate in a March 11 webinar that discusses pediatric health impacts caused by racism and poverty.

In a story about interim and preliminary results of a safety clinical trial prompting the FDA to warning the rheumatoid arthritis drug tofacitinib carrying an increased risk of heart issues and cancer among older patients, Kevin Winthrop, M.D., M.P.H., says “To be honest, it’s hard to know what to think. We need to see the data in the analysis.”

The Oregon Poison Center warns against using generators indoors and creating alternative ways to cook and produce during a blackout to avoid carbon monoxide exposure.

Donna Hansel, M.D., Ph.D., reflects on a year of the pandemic, including the biggest discoveries and challenges so far.

A feature about the growth of the biotech sector in Oregon reference's OHSU's collaboration with NanoString Technologies to develop a new breast cancer detection technology.

While discussing an OHSU study that found antibodies generated by SARS-CoV-2 react to other strains of coronavirus and vice-versa, Fikadu Tafesse, Ph.D., says “I do not think there is any one size-fits-all vaccine. Although the vaccines coming out now may break the momentum of the virus and end the pandemic, they may not be the end game.”

Spine Universe cites new research by Atul Deodhar, M.D., regarding the use of tofacitinib to treat ankylosing spondylitis.

Esther Choo, M.D., is featured in a panel discussion about the unique mental stress of the latest surge in the pandemic.

In a story about four medical societies issuing a statement about the safe use of hydroxychloroquine to treat ocular toxicity, James Rosenbaum, M.D., says “The goal of retinal screening is to safely maintain the use of this valuable medication for as long as possible for patients with rheumatic diseases, including cutaneous manifestations of rheumatic diseases.”

A story questioning law enforcement’s use of tear gas and smoke for crowd control quotes an OHSU statement: “Chemical means to control crowds has raised great concern among medical professionals as we simultaneously try to manage a global pandemic."